HIGHLIGHTS
- who: Yentl Huybrechts et al. from the Laboratory of Pathophysiology, University of Antwerp, Antwerp, Belgium have published the paper: Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover, in the Journal: Nutrients 2023, 598 of /2023/
- what: The authors aim to investigate in the context of ROD to which extent an association exists between and the abundance of osteocytes and expression in both the trabecular and cortical compartments. The aim of this study is to further unravel the PTH-sclerostin interaction and to evaluate the diagnostic potential of sclerostin as a biomarker by investigating . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.